1. 输入关键词后点击检索按钮可查询指定关键词在语料中的对应情况
  2. 选择语种可限定关键词的语言,当前支持中文和英文,默认选择中文
  3. 主题选项中可限定检索语料的文章主题范围,默认全部主题
  4. 主题选项中可限定检索语料的文本类型范围,默认全部类型
  5. 在结果列表中,点击操作栏中的“查看中文全文”或“查看英文全文”按钮可查看该句所在的中文语料全文
句对齐列表 共 16269 个结果  
序号 中文 英文 操作
12741 根据这一意见和所获信息,总干事宣布2014-2015年在这些西非国家出现的埃博拉疫情继续构成国际关注的突发公共卫生事件 Based on this advice and information, the Director-General declared that the 2014-2015 Ebola outbreak in these West African countries continues to constitute a Public Health Emergency of International Concern.
12742 总干事认可了委员会的意见,并将这一建议作为根据《国际卫生条例》提出的临时建议予以发布。 The Director-General endorsed the Committee’s advice and issued that advice as Temporary Recommendations under the IHR.
12743 这些临时建议取代并替换以往在西非埃博拉疫情背景下按照《国际卫生条例》发布的所有建议。 These Temporary Recommendations supersede and replace all previous recommendations issued under the IHR in the context of the Ebola Outbreak in West Africa.
12744 总干事感谢委员会委员和顾问提出的意见并请其在3个月内视情况需要对情势再次实施评估 The Director-General thanked the Committee members and advisors for their advice and requested their reassessment of this situation within 3 months should circumstances require.
12745 世卫组织和药品专利池宣布了第一个针对一项COVID-19技术的全球透明和非排他性许可 西班牙国家研究委员会为COVID-19技术获取池提供血清学检测技术 WHO and MPP announce the first transparent, global, non-exclusive licence for a COVID-19 technology CSIC offers serological test to C-TAP
12746 2021年11月23日 | 联合新闻发布 | 日内瓦 23 November 2021 | Joint News Release | Geneva
12747 今天,世卫组织COVID-19技术获取池和药品专利池签署了向西班牙国家研究委员会提供一种COVID-19血清学抗体技术的许可协议。 WHO’s COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP) today finalized a licensing agreement with the Spanish National Research Council (CSIC) for a COVID-19 serological antibody technology.
12748 这种检测技术能够有效发现感染COVID-19或接种疫苗之后是否形成SARS COV-2抗体 The test effectively checks for the presence of anti-SARS-CoV-2 antibodies developed either in response to a COVID-19 infection or to a vaccine.
12749 这是第一个针对COVID-19卫生工具的全球透明和非排他性许可,也是由药品专利池签署的第一个检测许可,已被纳入世卫组织技术获取池。 This represents the first transparent, global, non-exclusive licence for a COVID-19 health tool, and the first test licence signed by MPP and included in the WHO Pool.
12750 许可的目的是为西班牙国家研究委员会在全球快速生产和推广COVID-19血清学检测工具提供便利。 The aim of the licence is to facilitate the rapid manufacture and commercialization of CSIC’s COVID-19 serological test worldwide.